Application of AI in IVD Industry

Nowadays, Al is being applied more and more frequently in various industries, including in vitro diagnostics. Taking hematology analyzer as an example, under the constant update and iteration, various hematology analyzer products such as 3-part, 5-part and analysis workstation have appeared, which have a great innovation and improvement, Then, what are the trends of future hematology products? Al will be one of them.

In the high-end market for hematology products, including specialized hospitals like cancer hospitals, maternity and child hospitals, the comprehensive diagnosis of diseases such as leukemia, lymphoma and special anemia is increasingly challenging.

At the request of the WHO, abnormal hematological diseases are generally combined with a variety of test results, such as CBC test, cell morphology, cytogenetics, etc., to further help the diagnosis. As we know, hematology analysis is generally the first tool of malignant blood diseases. At the same time, the application of Al technology will bring new ideas to the initial screening of special diseases in blood analysis.

Innovation of AI in Hematology

Recently, an online academic sharing meeting themed as "Discussing the development trend of high-end hematology analyzer in the new era" has been held by Dymind and Latin American hematology experts jointly, in which Dr. Luis Figueroa Montes shared the innovation of artificial intelligence in hematology.

"

Nowadays, there are so many parameters on the hematology analyzers, most of which can only provide simple Flag information. When doctors are faced with a large amount of data but do not have enough time to analyze and process it, they may experience "information confusion" or "information overload". As the information accumulates, clinicians will be affected by excessive workload, resulting in omission of a lot of critical information.

Clinicians could benefit substantially from the application of Al-based approaches, which could reduce the workload, merge knowledge of different experts, decrease turn-around time and minimize technically induced misclassifications. The accurate interpretation of results depends a lot on a doctor's level of experience and reliable Al-based clinical prompt systems could establish confidence in unexperienced clinicians as well as provide new ideas for auxiliary diagnosis of diseases.

Dymind AI Cube Technology

As an innovator of hematology products, Dymind put different needs of customers as top priority.

The company is committed to innovation in high-end products , combining Al with hematology analyzer and launching Al Cube technology on DH-615.

Compared with the traditional flag alarming function, more comprehensive information for the analysis and prompt of diseases are available in Al Cube technology, which is truly interpretable for analysis of diseases, rather than simply providing a certain conclusion. Al analysis and its details are as below:

On the basis of the text description, dymind also combined it with the corresponding preprocessed graphics. With the Al technology, the graphics of the normal group and the corresponding diseases of different degrees are provided for the reference of clinicians, which is more intuitive and clear.

Dymind has realized the perfect combination of Al analysis technology and DMS (Data Management System) in a hematology analyzer, acomplishing technical integration and providing an auxiliary diagnostic system with higher compatibility.

As a professional IVD solution innovatior, in the future, Dymind will focus on developing more advanced technologies and more robust products. Dymind also hope that Al technology will be more widely used in the field of blood analysis so as to provide more reliable auxiliary basis and more comprehensive solutions for clinical laboratories.